Uruguay Vaccine Industry Outlook 2024 - 2028

See how Uruguay Vaccine performed compared to key markets.

Key Market Indicators

Uruguay's vaccination coverage for children aged one is projected to decline slightly to 91% by 2028, down from the current 92% in 2023. This represents a modest average annual decrease of 0.2 percentage points. Since 1985, the coverage rate has seen a gradual increase of 0.2 percentage points annually. In contrast, Uruguay's vaccine imports are on an upward trajectory. By 2028, imports are expected to reach approximately $11.6 million, up from $10.8 million in 2023. This marks an average annual growth rate of 1.1%. Since 1999, the country's demand for vaccines has shown a consistent increase of 3.9% each year. On the export front, Uruguay has seen a dramatic rise. Vaccine exports surged to $337,250 in 2015, a staggering increase of 1,030% from the $29,820 recorded in 2014. Since 2001, Uruguay's vaccine supply for export has grown at an impressive average annual rate of 95.9%.

Uruguay Vaccine Market Data and Forecasts

How much will Uruguay Vaccine Market grow to 2028?

Forecast: Import of Vaccines for Human Use to Uruguay

Other Top Countries about Vaccine